Booz Allen Hamilton Holding Corporation (BAH) Cash Flow Statement

The aggregate 1.21x conversion is comfortably above 1.0 and would ordinarily signal high earnings quality, but it is propped up by depreciation and stock compensation add-backs rather than by expanding cash economics. The two weakest quarters, 2025Q1 at 0.31x and 2026Q1 at 0.44x, both show working capital consuming roughly $190-220M, so investors should treat any single-quarter conversion reading as noise and anchor instead on the trailing four-quarter profile. Notably, conversion has improved to 1.17-1.62x in the three most recent quarters even as revenue contracted, which may indicate collections are holding up better than the top line.

Because the entire cumulative gap is approximately explained by non-cash charges, the divergence does not by itself argue for improving cash economics; the working capital line actually subtracted about $193M over the same window, partially offsetting those add-backs. This composition means the cash-versus-earnings premium is structurally durable as long as D&A stays elevated, but it would compress if the asset base is ever written down or if SBC is normalized as a real cost. The relevance to valuation is that BAH's cash flow looks stronger than its modest operating margin would suggest only because the P&L carries a heavy amortization load.

The year-over-year erosion occurred even though net income rose to $181M from $175M, which implies the shortfall sits entirely in operating cash conversion and working capital rather than in profitability, consistent with the swing from a $175M working capital source to only $39M. Against peers, BAH's recent 9.3-9.5% FCF margins sit between SAIC's 8.7% and LDOS's 10.0% and well below CACI's 13.1%, suggesting the premium multiple is not currently underwritten by superior cash generation. The longer FCF margin range of 0.7% to 17.9% across the ten quarters argues against extrapolating any single quarter's margin as a run-rate.

Every first quarter in the series consumed cash, with 2025Q1 at -$189M and 2026Q1 at -$219M, while second quarters rebuilt it, implying a structural billing and payment cycle rather than deteriorating receivables quality. The encouraging signal is that the 2027Q1 drain narrowed to just $36M versus $219M a year earlier, which may indicate faster collections or a change in contract mix, though one data point is insufficient to call a trend. Investors should monitor whether the smaller Q1 outflow persists, because if it does, the reported operating cash flow volatility should compress materially.

The gap between roughly $3.5B of deployed capital and $2.39B of cumulative free cash flow suggests the shortfall has been funded from the balance sheet, a pattern consistent with the strained leverage profile flagged in the income statement analysis. The sequencing deserves scrutiny: repurchases continued at $98M in 2027Q2, the same quarter as a $714M net acquisition outflow, which may indicate management is prioritizing capital return cadence over balance sheet flexibility rather than pausing buybacks to fund M&A. Dividends have remained steady in a narrow $65-73M band throughout, so the discretionary swing factor for investors is clearly the buyback, not the dividend.